Company NewsConference News Avance Clinical Releases Industry Survey Results at BIO Korea 2021 – Data Quality the Top Criteria for Selecting a CRO The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance…News EditorMay 29, 2021
Company AwardsCompany News Avance Clinical Wins Excellence in Business Award 2021 The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance…News EditorMay 21, 2021
Company AwardsCompany News Avance Clinical Expands Gene Technology Clinical Trial Services to Meet $17.4 billion Market Demand The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner, Avance…News EditorMay 6, 2021
Company NewsPartner News Avance Clinical Invited to Present “Decentralized Trials – No Going Back” for Oracle Health Sciences Connect The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance…News EditorApril 22, 2021
Client News Avance Clinical Client Atossa Therapeutics Announces Final Results from Phase 1 Clinical Study Showing Safety and Tolerability of AT-301 Nasal Spray Being Developed for COVID-19 The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance…News EditorMarch 14, 2021